Crashing Excel to Curing Cancer — How AI and Open Science Are Rewiring Drug Discovery

Welcome to AI on the Hill, the podcast where we explore the intersection of artificial intelligence and biotechnology, featuring thought leaders and innovators who are shaping the future of drug development and health tech. In this series, host René Bastón, Venture Partner at Covenant Venture Capital, and expert guests like Tommy Tang, Director of Bioinformatics at AstraZeneca, discuss cutting-edge topics in bioinformatics, AI in healthcare, and personalized medicine. Tommy Tang shares his inspiring journey from a nervous first-time immigrant landing in the U.S. with only $2,000 to becoming a bioinformatics leader. In this show, we dive into Tommy's transition from traditional wet-lab research to computational biology, and how he taught himself data science skills in R, Python, and Unix to drive his career. Tommy, also an advocate for open science, discusses the importance of sharing knowledge to advance scientific progress and make complex research more accessible. Join us as we explore how AI and bioinformatics are transforming cancer drug discovery, and learn about the practical impact of computational biology in shortening drug development timelines. Tommy’s insights into time management, leadership, and open science are a must-listen for anyone interested in the rapidly evolving world of biotech. You can connect with our host, René Bastón, on LinkedIn: https://www.linkedin.com/in/renebaston/ And our guest, Tommy Tang, on LinkedIn: https://www.linkedin.com/in/🎯-ming-tommy-tang-40650014/ For more information on any of the topics discussed, visit the Hill Research Podcast at https://www.hillresearch.ai/podcast.